Literature DB >> 20949386

Biobanks and registers in epidemiologic research on cancer.

Eero Pukkala1.   

Abstract

The Nordic countries have a long tradition of register-based epidemiologic studies. Numerous population-based specialized registers offer high-quality data from individuals, and the extensive use of register data further improves the quality of the registers. Unique personal identity codes given to every resident and used in all registers guarantee easy and accurate record linkage. A legislation that makes the use of the existing data possible for purposes that benefit both registered individuals and the society - instead of forcing researchers to use their energy in repeated questionnaire studies, disturbing individuals' privacy and leading to response and recall biases - is a prerequisite for effective epidemiologic research. Biobanks can be considered an additional type of registers. They may offer data from individuals that cannot be reliably collected via questionnaire surveys. In turn, other types of registers are crucial in biobank-based studies (1) in defining for how long the persons in biobank cohorts are at risk of getting the diseases, (2) to get information on cofactors that may modify the relative risk measured by the biomarkers, and (3) to get information on the long-term outcome events. This chapter describes the possibilities of register use mainly in Finland - a typical representative of the Nordic "paradise of register-based epidemiological research" - in research of cancer etiology. The ongoing Nordic research project Changing work life and cancer risk in the Nordic countries (NOCCA) will be described as an example of a massive register use, including both direct linkages on an individual level and indirect group level linkages.

Entities:  

Mesh:

Year:  2011        PMID: 20949386     DOI: 10.1007/978-1-59745-423-0_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

Review 1.  Genome privacy: challenges, technical approaches to mitigate risk, and ethical considerations in the United States.

Authors:  Shuang Wang; Xiaoqian Jiang; Siddharth Singh; Rebecca Marmor; Luca Bonomi; Dov Fox; Michelle Dow; Lucila Ohno-Machado
Journal:  Ann N Y Acad Sci       Date:  2016-09-28       Impact factor: 5.691

2.  Cancer incidence among Finnish people with type 2 diabetes during 1989-2014.

Authors:  Katri Saarela; Jaakko Tuomilehto; Reijo Sund; Ilmo Keskimäki; Sirpa Hartikainen; Eero Pukkala
Journal:  Eur J Epidemiol       Date:  2018-09-04       Impact factor: 8.082

3.  A follow-up of cancer incidence among former Finnish dump site residents: 1999-2011.

Authors:  Eero Pukkala
Journal:  Int J Occup Environ Health       Date:  2014-10

4.  Cancer incidence among Finnish ferrochromium and stainless steel production workers in 1967-2011: a cohort study.

Authors:  Markku Huvinen; Eero Pukkala
Journal:  BMJ Open       Date:  2013-11-19       Impact factor: 2.692

5.  Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.

Authors:  Mathias Meijer; Lau Caspar Thygesen; Anders Green; Martha Emneus; Klaus Brasso; Peter Iversen; Eero Pukkala; Kristian Bolin; Knut Stavem; Annette K Ersbøll
Journal:  Cancer Med       Date:  2017-12-13       Impact factor: 4.452

6.  Cancer incidence among Finnish male cobalt production workers in 1969-2013: a cohort study.

Authors:  Riitta Sauni; Panu Oksa; Jukka Uitti; Asko Linna; Raimo Kerttula; Eero Pukkala
Journal:  BMC Cancer       Date:  2017-05-18       Impact factor: 4.430

7.  One-carbon metabolite ratios as functional B-vitamin markers and in relation to colorectal cancer risk.

Authors:  Björn Gylling; Robin Myte; Arve Ulvik; Per M Ueland; Øivind Midttun; Jörn Schneede; Göran Hallmans; Jenny Häggström; Ingegerd Johansson; Bethany Van Guelpen; Richard Palmqvist
Journal:  Int J Cancer       Date:  2018-12-07       Impact factor: 7.396

8.  A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease.

Authors:  Fredrik Åberg; Christopher J Danford; Maja Thiele; Mats Talbäck; Ditlev Nytoft Rasmussen; Z Gordon Jiang; Niklas Hammar; Patrik Nasr; Mattias Ekstedt; Anna But; Pauli Puukka; Aleksander Krag; Jouko Sundvall; Iris Erlund; Veikko Salomaa; Per Stål; Stergios Kechagias; Rolf Hultcrantz; Michelle Lai; Nezam Afdhal; Antti Jula; Satu Männistö; Annamari Lundqvist; Markus Perola; Martti Färkkilä; Hannes Hagström
Journal:  Hepatol Commun       Date:  2021-03-08

9.  Nationwide registry-based analysis of cancer clustering detects strong familial occurrence of Kaposi sarcoma.

Authors:  Eevi Kaasinen; Mervi Aavikko; Pia Vahteristo; Toni Patama; Yilong Li; Silva Saarinen; Outi Kilpivaara; Esa Pitkänen; Paul Knekt; Maarit Laaksonen; Miia Artama; Rainer Lehtonen; Lauri A Aaltonen; Eero Pukkala
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  A 30-Year Prospective Follow-Up Study Reveals Risk Factors for Early Death in Cartilage-Hair Hypoplasia.

Authors:  Svetlana Vakkilainen; Mervi Taskinen; Paula Klemetti; Eero Pukkala; Outi Mäkitie
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.